- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/29 - Virus de l'hépatite
Détention brevets de la classe A61K 39/29
Brevets de cette classe: 1067
Historique des publications depuis 10 ans
|
88
|
60
|
78
|
86
|
61
|
67
|
56
|
51
|
46
|
22
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4414 |
31 |
| The Governors of the University of Alberta | 875 |
31 |
| Janssen Sciences Ireland Unlimited Company | 375 |
26 |
| Glaxosmithkline Biologicals S.A. | 1601 |
25 |
| Xiamen University | 575 |
17 |
| The Johns Hopkins University | 5875 |
14 |
| Hvidovre Hospital | 64 |
13 |
| GlobeImmune, Inc. | 72 |
12 |
| The Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 60 |
11 |
| Oxford University Innovation Limited | 1658 |
11 |
| Transgene S.A. | 115 |
11 |
| The Regents of the University of California | 20720 |
10 |
| Gilead Sciences, Inc. | 2220 |
10 |
| Japan as Represented by Director-General of National Institute of Infectious Diseases | 71 |
10 |
| Tokyo Metropolitan Institute of Medical Science | 114 |
10 |
| The Wistar Institute of Anatomy and Biology | 484 |
10 |
| Toko Yakuhin Kogyo Co., Ltd. | 32 |
10 |
| The Regents of the University of Michigan | 4979 |
9 |
| University of Washington | 2443 |
9 |
| Xiamen Innovax Biotech Co., Ltd. | 110 |
9 |
| Autres propriétaires | 778 |